ANTX — AN2 Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for AN2 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.6	96.1	107	83.6	58
Prepaid Expenses
Total Other Current Assets
Total Current Assets	60.1	98.6	111	86.3	59.9
Long Term Investments
Other Long Term Assets
Total Assets	65.3	103	139	92.1	62
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.4	7.19	14	10.2	8.72
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.41	7.19	14	10.2	8.89
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	61.9	95.4	125	81.8	53.1
Total Liabilities & Shareholders' Equity	65.3	103	139	92.1	62
Total Common Shares Outstanding